Advanced search
Publication Cover
Journal of Asthma Volume 59, 2022 - Issue 1
Submit an article Journal homepage
338
Views
7
CrossRef citations to date
0
Altmetric
Pharmacotherapy

Perceptions, attitudes, and behaviors of short-acting beta2 agonist users: an Australian cross-sectional community pharmacy-based study

Elizabeth Azzia Quality Use of Respiratory Medicines, Clinical Management, Woolcock Institute of Medical Research, Glebe, Australia;b School of Medicine and Health, The University of Sydney, Sydney, AustraliaCorrespondence[email protected]
, PhD,
Vicky Kritikosa Quality Use of Respiratory Medicines, Clinical Management, Woolcock Institute of Medical Research, Glebe, Australia
, PhD,
Matthew Petersc Respiratory Medicine, Concord Repatriation General Hospital, Concord, Australia;d Emphysema Centre, Woolcock Institute of Medical Research, Glebe, Australia
, MBBS,
David Pricee Academic Primary Care, University of Aberdeen, Aberdeen, United Kingdom of Great Britain and Northern Ireland
, MBBS,
Biljana Cvetkovskia Quality Use of Respiratory Medicines, Clinical Management, Woolcock Institute of Medical Research, Glebe, Australia
, PhD,
Pamela Srour Alphonsea Quality Use of Respiratory Medicines, Clinical Management, Woolcock Institute of Medical Research, Glebe, AustraliaORCID Iconhttps://orcid.org/0000-0003-4825-1215
, PhDORCID Icon &
Sinthia Bosnic-Anticevicha Quality Use of Respiratory Medicines, Clinical Management, Woolcock Institute of Medical Research, Glebe, AustraliaORCID Iconhttps://orcid.org/0000-0001-5077-8329
, PhDORCID Icon show all
Pages 178-188 | Received 22 Sep 2019, Accepted 18 Oct 2020, Published online: 03 Nov 2020

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Zhe Chi Loh, Rabia Hussain, Siew Chin Ong, Bandana Saini, Jaya Muneswarao, Anees ur-Rehman & Zaheer-Ud-Din Babar. (2023) Over-the-counter use of short-acting beta-2 agonists: a systematic review. Journal of Pharmaceutical Policy and Practice 16:1.
Read now

Articles from other publishers (6)

David Price, Christine Jenkins, Kerry Hancock, Rebecca Vella, Florian Heraud, Porsche Le Cheng, Ruth Murray, Maarten Beekman, Sinthia Bosnic-Anticevich, Fabio Botini, Victoria Carter, Angelina Catanzariti, Joe Doan, Kirsty Fletton, Ata Kichkin, Thao Le, Chantal Le Lievre, Chi Ming Lau, Dominique Novic, John Pakos, Kanchanamala Ranasinghe, Alexander Roussos, Josephine Samuel-King, Anita Sharma, Deb Stewart, Bruce Willet, Eric Bateman, Rob Campbell, Ying Liu, Nicole O’Sullivan, Ondrej Rejda, Lisa Sugg, Steph James, Kiran Dhillon & Sophie Jones. (2024) The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia. Advances in Therapy 41:3, pages 1262-1283.
Crossref
Njira Lugogo, Maeve O’Connor, Maureen George, Rajan Merchant, Greg Bensch, Jay Portnoy, John Oppenheimer & Mario Castro. (2023) Expert Consensus on SABA Use for Asthma Clinical Decision-Making: A Delphi Approach. Current Allergy and Asthma Reports 23:11, pages 621-634.
Crossref
Sinthia Bosnic-Anticevich & Anne L. Fuhlbrigge. (2023) Getting Smart About Implementing SMART. The Journal of Allergy and Clinical Immunology: In Practice 11:9, pages 2778-2780.
Crossref
Christine R Jenkins, Philip G Bardin, John Blakey, Kerry L Hancock, Peter Gibson & Vanessa M McDonald. (2023) Sleepwalking towards more harm from asthma. Medical Journal of Australia 219:2, pages 49-52.
Crossref
Sara Alamyar, Elizabeth Azzi, Pamela Srour-Alphonse, Rachel House, Biljana Cvetkovski, Vicky Kritikos & Sinthia Bosnic-Anticevich. (2023) Uncovering the Burden of Rhinitis in Patients Purchasing Nonprescription Short-Acting β-Agonist (SABA) in the Community. Pharmacy 11:4, pages 115.
Crossref
Zhe Chi Loh, Rabia Hussain, Shamala Balan, Bandana Saini, Jaya Muneswarao, Siew Chin Ong & Zaheer-Ud-Din Babar. (2023) Perceptions, attitudes, and behaviors of asthma patients towards the use of short-acting β2-agonists: A systematic review. PLOS ONE 18:4, pages e0283876.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.